Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: CRVS) | Delayed: 10.39 -0.13 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.52 | 52 Week High | $17.77 | |||
| Open | $10.57 | 52 Week Low | $9.63 | |||
| Day High | $10.74 | P/E | N/A | |||
| Day Low | $10.32 | EPS | $0.00 | |||
| Volume | 271,001 | |||||
